2nd Quarter - Report

FARRAGUT PARTNERS LLP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Concerns regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Medicare Part B Demonstration

LobbyistCovered position, as disclosed
JODY SHINTARO GALE —
JEFF MACKINNON LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Monitor Drug Safety and pedigree legislation. Medicare Part B Demonstration

LobbyistCovered position, as disclosed
JODY SHINTARO GALE —
JEFF MACKINNON LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Health Issues HCR

Issues related to the implementation of the follow-on biologics provisions in P.L. 111148 "Patient Protection and Affordable Care Act". Medicare Part B Demonstration

LobbyistCovered position, as disclosed
JODY SHINTARO GALE —
JEFF MACKINNON LD & LA Rep. Joe Barton (RTexas)
JEFFERY C. MORTIER Prof Staff on E&C Cmte and LA Rep Whitfield
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.